Glimepiridpulver 99.36% Pharmazeutische Rohstoffe CAS 93479-97-1
Pharmaceutical Raw Materials Glimepiride Powder,99.36% Glimepiride
Molekularformel:C24H34N4O5S
Formelgewicht: 490.62
CAS-Nr.:93479-97-1
Reinheit:99.36%
Aussehen: off white powder
Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea,or as second-generation.
Glimepiride is indicated to treat type 2 diabetes mellitus; its mode of action is to increase insulin production by the pancreas. It is not used for type 1 diabetes because in type 1 diabetes the pancreas is not able to produce insulin.
Its use is contraindicated in patients with hypersensitivity to glimepiride or other sulfonylureas.
Das Echtheitszertifikat:
| Produktname |
Glimepiride |
| CAS-Nr. |
93479-97-1 |
Äußere Verpackung |
25KG/Fass |
| Produktionsdatum |
2016.7.12 |
Haltbarkeit |
2019.07.11 |
| Norm übernommen |
Unternehmensstandard |
| Elemente der Analyse |
Spezifikation |
Ergebnisse |
|
Aussehen |
White or off white powder |
off white powder |
|
Löslichkeit |
Two soluble in dimethylformamide, soluble in dichloromethane two chloride, schwer löslich in Methanol, praktisch unlöslich im Wasser |
Entspricht |
| Identifizierung |
IR map should be consistent with the control map |
Entspricht |
| Schwermetall |
≤ 10 ppm |
Entspricht |
| Cis-isomer(EIN) |
≤0.8% |
0.20% |
|
Sulfonamide(B) |
≤ 0,4% |
0.11% |
| Urethane(C) |
≤0,1 % |
ND |
| 3-isomer(D) |
≤0,2 % |
ND |
| Any other impurity |
≤0,1 % |
0.08% |
| Gesamtverunreinigungen |
≤0,5 % |
0.12% |
| Glührückstand |
≤0,2 % |
0.08% |
| Trocknungsverlust |
≤0,5 % |
0.16% |
| Assay |
98.0% ~102.0 % |
99.36% |
| Fazit |
Qualifiziert |